Published in TB and Outbreaks Week, July 17th, 1995
It has been reported that human peripheral blood mononuclear cells (PBMC) can be adoptively transferred intraperitoneally (IP) into the severe combined immune deficiency (SCID) mouse and that the engrafted cells survive for an extended period of time producing high levels of human Ig. This has offered many new possibilities in clinical immunology research, but major drawbacks to this approach include the impaired fuctionality of the engrafted human lymphocytes.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.